Unveiling ANI (ANIP) Q4 Outlook: Wall Street Estimates for Key Metrics

Wall Street analysts forecast that ANI Pharmaceuticals (ANIP) will report quarterly earnings of $0.80 per share in its upcoming release, pointing to a year-over-year increase of 5.3%. It is anticipated that revenues will amount to $123.02 million, exhibiting an increase of 30.6% compared to the year-ago quarter.Over the last 30 days, there has been an upward revision of 16.9% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsi ...